General Information of Drug (ID: DM7M5VY)

Drug Name
NITROCEFIN Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
6436140
TTD Drug ID
DM7M5VY

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cefalotin DMVYSLE Bacteremia 1A73 Approved [2]
B-Lactams DMR8YD6 Bacterial infection 1A00-1C4Z Approved [3]
Cephalosporin DM79XDW Bacterial infection 1A00-1C4Z Approved [4]
Cefotaxime DMEB837 Bacteremia 1A73 Approved [5]
TD-1792 DMGKBZH Skin infection 1F28-1G0Z Phase 3 [6]
Phenyl Boronic acid DMFZH49 Discovery agent N.A. Investigative [7]
Cephalosporin C DMYW3ZG Discovery agent N.A. Investigative [8]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [9]
D-Alanine DMVIDQL Discovery agent N.A. Investigative [9]
3-boronobenzoic acid DMRCJW0 Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial DD-carboxypeptidase (Bact vanYB) TTLP6GN VANY_ENTFA Inhibitor [1]

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
2 Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. Biochemistry. 1995 Jul 25;34(29):9532-40.
3 Has nature already identified all useful antibacterial targets Curr Opin Microbiol. 2008 Oct;11(5):387-92.
4 A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1427-31.
5 Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol. 2007 Jun;2:297-307.
6 How many modes of action should an antibiotic have Curr Opin Pharmacol. 2008 Oct;8(5):564-73.
7 Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors. J Med Chem. 2009 Oct 8;52(19):6097-106.
8 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
9 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.